Page last updated: 2024-08-21

2-aminopurine and Liver Cirrhosis

2-aminopurine has been researched along with Liver Cirrhosis in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (60.00)18.2507
2000's2 (40.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Angus, P; Bowden, S; Breschkin, A; Locarnini, S; McCaughan, G; Shaw, T; Sheil, R1
Main, J; McCarron, B; Thomas, HC1
Bechstein, WO; Budde, K; Hocher, B; Krüger, DH; Meisel, H; Neuhaus, P; Neumayer, HH; Preikschat, P; Reinke, P1
Airoldi, A; Pinzello, G; Zavaglia, C1
Chaudhary, R; Fonseca, K; Lee, SS; Myers, RP1

Reviews

2 review(s) available for 2-aminopurine and Liver Cirrhosis

ArticleYear
Treatment of chronic viral hepatitis.
    Antiviral chemistry & chemotherapy, 1998, Volume: 9, Issue:6

    Topics: 2-Aminopurine; Animals; Antimetabolites; Antiviral Agents; Carcinoma, Hepatocellular; Disease Models, Animal; Drug Therapy, Combination; Ducks; Famciclovir; Female; Hepatitis B, Chronic; Hepatitis C, Chronic; Hepatitis, Animal; Humans; Immunologic Factors; Interferon-alpha; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Male; Marmota; Poultry Diseases; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Tumor Cells, Cultured

1998
Antiviral therapy of HBV- and HCV-induced liver cirrhosis.
    Journal of clinical gastroenterology, 2000, Volume: 30, Issue:3

    Topics: 2-Aminopurine; Antiviral Agents; Clinical Trials as Topic; Famciclovir; Female; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon-alpha; Lamivudine; Liver Cirrhosis; Male; Prognosis; Reverse Transcriptase Inhibitors; Survival Rate; Thymalfasin; Thymosin; Treatment Outcome

2000

Other Studies

3 other study(ies) available for 2-aminopurine and Liver Cirrhosis

ArticleYear
Retransplantation for precore mutant-related chronic hepatitis B infection: prolonged survival in a patient receiving sequential ganciclovir/famciclovir therapy.
    Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 1996, Volume: 2, Issue:6

    Topics: 2-Aminopurine; Antiviral Agents; DNA, Viral; Famciclovir; Follow-Up Studies; Ganciclovir; Graft Rejection; Graft Survival; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Cirrhosis; Liver Function Tests; Liver Transplantation; Male; Middle Aged; Reoperation

1996
Disappearance of hepatitis B virus core deletion mutants and successful combined kidney/liver transplantation in a patient treated with lamivudine.
    Transplant international : official journal of the European Society for Organ Transplantation, 1999, Volume: 12, Issue:4

    Topics: 2-Aminopurine; Antiviral Agents; DNA, Viral; Famciclovir; Follow-Up Studies; Genetic Variation; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunosuppressive Agents; Kidney Transplantation; Lamivudine; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Mutation; Renal Dialysis; Sequence Deletion

1999
Fatal hepatic decompensation in a patient with hepatitis B cirrhosis following famciclovir withdrawal.
    Canadian journal of gastroenterology = Journal canadien de gastroenterologie, 2000, Volume: 14, Issue:8

    Topics: 2-Aminopurine; Adult; Antiviral Agents; Famciclovir; Fatal Outcome; Hepatitis B; Humans; Liver Cirrhosis; Liver Failure; Male; Time Factors; Virus Replication

2000